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THE EFFECT OF ALTERED PROPERDIN LEVELS IN MICE ON THE COURSE
OF SYSTEMIC MYCOTIC INFECTIONS*
EARL G. McNALL, PH.D., V. D. NEWCOMER, M.D. AND T. H. STERNBERG, M.D.
It is well known that natural immunity plays
an important part in the systemic fungal infec-
tions. At the time of the primary infections, the
host resistance is an important consideration in
whether dissemination of the disease takes place
or does not take place (1, 2). Differences in
susceptibility to primary infections as well as
dissemination have been reported as a function of
race within endemic areas of coccidioidomycosis
(1,3).
Properdin is a euglobulin present iii serum
which has been shown to play a significant part
in natural immunity (4). Together with comple-
ment or "complement like" components and
magnesium ions, properdin inactivates New-
castle's Disease virus and T2 phage of E. coli,
causes lysis of certain gram negative organisms,
and increases granulocyte phagocytosis of Staphy-
lococcus pyogenes (4, 5, 6, 7, 8). Several assays
for properdin are based on these viral and mi-
crobial inhibiting effects (6, 7). The more specific
assays, however, depend upon the selective in-
activation of C'3 in the presence of either inulin
or zymosan (4, 9). Zymosan has been used for
altering serum properdin levels in experimental
animals (4, 7, 10, 11).
This paper reports the effect of inulin and
zyniosan on the course of systemic Coccidioides
immitis and Blastomyces dermatitidis infections
and on the properdin levels of inulin and zymosan
injected mice.
MATERIALS AND METHODS
1. Properdin assay. Properdin was determined
by the inulin assay technic using materials and
methods reported previously (9, 14), with the
following modification. Instead of using crystal-
line inulin, this compound was solubilized in
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buffer by heat. The centrifuging prior to the
addition of sensitized sheep cells was omitted.
2. Inulin. Powdered dahlia inulin of a mean
chain length of 30 residues of fructose per mole-
cule with an optical rotation of —39° was ob-
tained from commercial sources.t This inulin
was uniformly suspended in saline such that
the final volume for each injection was contained
in 0.1 ml. saline.
3. Zymosan. Zymosan was ground in a mortar
and pestle to a fine powder and uniformly sus-
pended in physiological saline.
EXPERIMENTAL
Swiss-Webster mice weighing between 20 and
23 gms. were divided into groups of 25 animals
each. The control group received saline injections
every third day of the experiment; the inulin
control group received 1000 mg. of inulin per kg.
of body weight beginning three days prior to
infection and every third day subsequently. The
organism control group were inoculated intra-
peritoneally with Coccidioides immitis. The inocu-
lation was prepared from mycelial mats grown at
room temperature in Mycophil broth overlaid
with mineral oil. These mats were ground in a
Ten Brock tissue grinder with sterile saline
containing 80 units tetracyclene/mi. The inocu-
lum consisted of 0.1 ml. of this preparation and
contained 58,000 fragments of hyphae. Another
group inoculated with Coccidioides inimitis as
above was injected three days prior to infection
with 1000 mg/kg inulin intraperitoneally. An
additional group was inoculated with Coccidioides
immitis but injected three days prior to infection
and every third day subsequently with 1000
mg/kg of inulin. The last group in this experiment
was inoculated with Coccidioides immitis and
injected with 125 mg/kg of inulin three days
prior to infection, and every subsequent third
day.
The same series of experimental groups were
used in the Blastomyces dermatitidis experiments
t Difco Corp. lot 427865.
Fleishman Laboratories, Standard Brands,
Stamford, Connecticut, lot 5Bl71.
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except the inoeula consisted of 0.2 ml. of 40%
suspension of the yeast phase organism per ani-
mal in Experiment 1 and 0.2 ml. of 20% suspen-
sion of yeast phase organism in Experiment 2.
EE5ULT5
The influences of inulin and zymosan on
properdin levels are shown in Table I. Injections
of inulin or zymosan decrease the properdin level
to an extent dependent upon the dosage and
route of administration. At a dosage level of
1000 mg/kg body weight, the properdin level
decreases markedly within the first 12 hours to
less than one-third of the original level and is
maintained at this level for periods between 48
and 72 hours. Inulin injections at this level
spaced every three days maintain properdin
levels at about one-third the original level.
Zymosan at this concentration was not as well
tolerated as inulin. Animals injected with 125
mg/kg of inulin or zymosan at 125 mg/kg exhibit
a depression of properdin which persists for less
than one day and rises on the second day to a
level consistently higher than the original con-
centration.
Animals injected with an overwhelming inocu-
TABLE I
Effect of inulin and zyniosan on properdin levels
Inulin (mg/
kg)
100
500
1000
Zymosan
(mg/kg)
100
500
of mice
The inulin and zylnosan were finely powdered
in a mortar and pestle and uniformly suspended
in physiological saline in a final volume of 0.1 ml.
Properdin levels at zero time were prior to ad-
ministration of polysaeeharides. Samples taken
thereafter were obtained from tail capillary
blood. The values shown are from pools of 5 mice
in each group.
lum of C. immitis had a 50% mortality on the
12th day (Experiment 1, Table II). Those treated
with 1000 mg/kg of inulin three days prior to
inoculation and every subsequent third day had
a 50% mortality on the sixth day. On the fifth
day of this experiment 40% of the 1000 mg/kg
inulin-treated animals were dead, whereas none
of the animals in the organism control nor those
treated with 125 mg/kg inulin had died. Partial
protection was afforded the infected group which
received the lower level of inulin. This was also
observed in experiments utilizing low levels of
zymosan injections (Experiment 3, Table II).
A more dramatic effect of artificially lowered
properdin levels on mortality was seen with ani-
mals infected with B. dermatitidis. (Table III).
The organism control had a 50% mortality on
the 11th day of the experiment, whereas animals
repeatedly injected with the higher dosage level
of inulin had a 50% mortality on the fifth day of
the experiment. The rate of death in the two
other experimentally infected groups treated
with inulin was intermediate.
TABLE II
Coccidioides iinrnitis
Experiment
Ex-
peri-Experiroent
2 (In- san*)
ulin)
Experimental Group 3
h
.sH
.
!f
Fo
.dH
!
.H
!
.6H
Organism control
Organism + inulin ad-
40 ministered IP 3 days
38 prior to inoculation...
io Organism + inulin ad-
ministered IP 3 days
prior to inoculation
38 and every subsequent
36 3rd day
Organism + inulin ad-
ministered IV 3 days
prior to inoculation
and every subsequent
3rd day
* Zymosan substituted for inolin.
Note: No deaths occurred in the inulin or
zysnosan control groups.
Properdlo Levels
Time after Administratioo
72 hr
Route
IV
'P
'P
'V
'P
e Ihr Shr 24hr 4shr
28 10 12 30 35
31 8 10 27 34
27 19 10 11.5 13
32 7 14 28 36
28 11 14 20 36
12
7
6
13
70
43
17
125
13 16
7
5
18 20
18
26
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Organism control
Organism + inulin admin-
istered IP 3 days prior to
inoculation
Organism + inulin admin-
istered IP 3 days prior to
inoculation and every
subsequent 3rd day
Organism + inulin admin-
istered IV 2 days prior to
inoculation and every
sobsequent 2nd day
Experiment 1
Time
50 Timede 100%(days) dead
* One half the amount of inoculum used in ex-
periment 1 was used in experiment 2.
t 125 mg. inulin IV administered 24 hours
prior to organism.
Note: No deaths occurred in the inulin control
group.
DSSCUSSION
Properdin levels may be selectively decreased
by injection of inulin at suitable levels without
causing a nonspecific decrease in components of
complement. Dosage levels of inulin up to 1000
mg/kg of inulin intraperitoneally did not produce
accidental death, whereas this was occasionally
observed when zymosan was used at this dosage
level. A single I.P. injection of crystalline inulin
at a concentration of 1000 mg/kg I.P. gives
persistently decreased properdin levels for a
period of two to three days.
It is apparent that zymosan and inulin influ-
ence the course of C. immitis and B. dermatiticlis
infections in mice. Low levels of zymosan or inulin
decrease the rate of death whereas high levels
which produce prolonged depression of properdin
increase the death rate. The partial protective
effect of low dosages of inulin or zymosan cannot,
however, be fully explained on the basis of
properdin rebound as reflected by serum proper-
din levels following the injection of these com-
pounds. It is possible that inulin or zymosan
stimulates the formation of properdin which
might not be reflected in circulatory levels. There
is no method which at the present time can be
applied to determine whether increased resistance
at the cellular level exists.
A quantity of inoculum was purposely selected
(Inuim) which would produce a rapid death rate in order
Time to separate at least two maj or variables in the
experiment. An initial rapid rate of death helps
______
in some degree to separate the natural immune
35 system from antibody systems which might
become of greater importance in slower death rate
experiments. Admittedly these experiments are
not similar to infections observed in nature due
to this overwhelming quantity of inocula used.
Preliminary experiments which utilize low levels
21
of infectious material and more closely approxi-
mate the chronic disease state almost invariably
resulted in complex bi-phasic death rate curves.
These curves were undoubtedly composite death
52t curves in which the partial protection of the
naturally immune system is superimposed on the
partial or complete protection afforded by the
antibody system.
It is tempting to speculate that natural im-
munity which is afforded at least in part by the
properdin system may limit a primary infection
and allow acquired immune mechanisms to
develop. There is a large body of circumstantial
evidence which would tend to relate properdin
levels and susceptibility to C. immitis. Humans
with naturally acquired infections exhibit lower
properdin levels than healthy uninfected indi-
viduals of the same racial and age groups (16).
There is considerable evidence that negroes are
more susceptible to the disseminated form of
coccidioidomycosis. Evidence has been presented
which may explain, at least in part, this increased
susceptibility on the basis of markedly lower
properdin levels of some individuals of this race
(12).
It is also well known, for example, that desert
mice and other desert rodents are relatively
susceptible to the disseminated form of this dis-
ease (13), whereas dissemination of C. iminiti.s
is not known in horses, sheep, or cattle (14). The
properdin levels of the former group of animals
are much lower than those of the latter group
(15). It would be unwise, however, to draw
definite conclusions concerning the relationship
of properdin levels in these animals and their
relative resistances to C. immitis infections,
since in addition to properdin, other nonspecific
TABLE III
Blastomyces dermatitidis
Experiment Group
11 19
7 14
5 9
10 21
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factors may play a role here. Other species related
phenomena which have not thus far been inves-
tigated could also explain these differences in
susceptibility. Another indication of a causal
relation of the properdin system and C. immitis
infection has been reported; the antifungal anti-
biotic Amphotericin B protects C. immitis in-
fected mice, even when administered after the
organism has disseminated (16). The properdin
levels decrease two to three days following a
massive inoculation with C. immitis and con-
tinue to decrease until death. Following the
administration of Amphotericin B, properdin
levels approach normal range within two to
three days.
CONCLUSIONS
1. Serum properdin concentrations may be
decreased or increased by the administration of
inulin in a manner similar to zymosan.
2. Animals with artificially lowered properdin
levels are more susceptible to C. immitis and
B. dermatitidis infections than those receiving
organisms alone.
3. Partial protection may be afforded by low
levels of inulin or zymosan when challenged by
these organisms in the "rebound" phase.
REFERENCES
1. SMITH, C. E., PAPPAGIANIS, D. AND AITO,
M. T.: The public health significance of
Coecidioidomycosis, pp. 3—9, Proc. of Syim'
posium on Coccidioidomycosis, 1957.
2. SMITH, C. E., BEARD, R. R., WHITING, E. C.
ANn RO5ENBEEGEE, H. C.: Varieties of
coceidioidal infection in relation to the
epidemiology and control of the diseases.
Am. J. Pub. Health., 36: 1394—1402, 1946.
3. WILLETT, F. M. AND WEIss, A.: Coeeidioido-
mycosis in Southern California: Report of
a new endemic area with a review of 100
cases. Ann. Tnt. Med., 23: 349—75, 1945.
4. PILLEMEE, L., BLUM, L., LEpow, I. H., Ross,
0. A., TODD, E. W. AND WAEDLAW, A. C.:
The Properdin system and immunity. I.
Demonstration and isolation of a new serum
protein, properdin, and its role in immune
phenomena. Science, 120: 279—85, 1954.5. WEDGWOOD, R. J., GIN5BEEG, H. S. AND
PILLEMEE, L.: The Properdin system and
immunity. VT. The inactivation of New-
castle Disease virus by the properdin
system. J. Exper. Med., 104: 707—25, 1956.
6. VAN VANAKI5, H., BARLOW, J. L. AND LEVINE,
L.: Neutralization of bacteriophage by the
properdin system. Proc. Nat. Acad, Sc., 42:
391—94, 1956.
7. WAEDLAw, A. C. AND PILLEMEE, L.: The
properdin system and immunity. V. Thebactericidal activity of the properdin
system. J. Exper. Med., 103: 553—75, 1956.
S. NANNI, C.: Opsonic activity of properdin.
Experientia, 14: 23, 1957.
9. MCNALL, E. C.: Assay of properdin in bio-
logical fluids. Proc. Soc. Exper. Biol. &
Mcd., 94: 399—404, 1957.
10. PILLEMER, L. AND Ross, 0. A.: Alterations in
serum properdin levels following injection
of zymosan. Science, 121: 732, 1955.
11. PILLEMEH, L., SCHOENBERG, M. D., Burn, L.AND Wunz, L.: Properdin system and im-
munity. IT. Interaction of the properdin
system with polysaccharides. Science, 122:
545, 1955.
12. NEWCOMER, V. D., MCNALL, E. C., HALDE,
C., WEIGHT, E. T. AND STERNHERO, T. H.:
The evaluation of the level of properdin in
hormal adult humans and in certain disease
støtes. J. Invest. Dermat. 30: 233—36, 1958.
13. SWAnK, F. E. AND PLUNKETT, 0. A.: Ecologi-
cal studies on Coccidioides immitis. Ex-
perimental infections of wild rodents and
animals other than mammals. Proc. of
Symposium on Coccidioidomyeosis, pp. 161—
67, 1957,
14. PECHAL, C. J.: Coecidioidomycosis in Arizona
cattle. Proc. of Symposium on Coccidioido-
mycosis, pp. 105—6, 1957.15. MCNALL, E. C.: The characteristics of pro-
perdin in various animal species. Trans.
of 6th Congr. Europ. Soc. Haematol., 1957.
Karger, Basel/New York. pp. S949—54.
16. HALDE, C., 1\'ICNALL, E. C., NEWCOMEE,
V. D. ANn STEENHERO, T. H.: Properdin
levels in mice and man with Coecidioido-
mycosis during soluble Amphotericin B
administration. Antibiotics Annual, pp.
598—601, 1957—58.
DISCUSSION
DE. J. WALTER WILSON (Los Angeles, Calif.):
It is very pleasing to some of us to find another
bit of evidence leading to the conclusion that
polysaecharides are closely involved in specific
immunity to contagious diseases, because those
of ur interested in infections caused by Coccidi-
oides immitis and Blastomyces dermcztitidis be-
came convinced of that as early as 20 years ago.
Such advocates have always been saying that
the response to the skin test using specific poly-
saccharides revealed a patient's immunity level
and paralleled, at least, the patient's resistance
to eoeeidioidomyeosis or blastomycc sis. Instead
of paying tribute to the ordinary tuberculin
test, (which obviously has nothing to do with
resistance) it was pointed out that it is performed
with protein and it was long ago suggested that
additional search should be made in extracts
from the tuberele bacilli trying to find a polysac-
eharide whieb would reveal or at least parallel
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the patient's level of immunological resistance
at the time the test is done. Doctor Florence Sci-
bert has recently written that there is a relation-
ship to some specific polysaccharide in the
persons who actually resist tuberculosis infection.
Dn. EARL G. McNALL (in closing): I would
like to thank Dr. Wilson for his comment.
We are engaged in characterizing both chem-
ically and immunologically the polysaccharides
derived from C. immitis. In the course of studying
various polysaccharidc fractions from this organ-
ism we found one polysaccharide which has
properdin binding activity. In addition, another
fraction, a lipopolysaccharide, causes lysis of
red blood cells and exhibits a high level of anti-
complementary activity. The former polysac-
charide is made up of the same sugar moieties
as those which comprise the soluble polysac-
charide that the organism excretes into the
medium. The soluble polysaccharide, unless it is
at least partially degraded is anticomplementary.
It is for this reason that it is difficult to obtain
satisfactory complement fixation antigens from
this material. The mycelial phase organism,
through a process of autolysis releases polysac-
charides which are enzymically degraded to lower
and lower molecular weight classes such that
in order to obtain satisfactory complement fixing
antigens one has to almost by accident find a
culture supernatant or autolyzing mycelial prep-
aration which contains the polysaccharides just
sufficiently degraded that they are no longer
anticomplementary but still large enough to have
antigenic activity. Our aim in this phase of our
work is to devise methods for preparing chemi-
cally descript polysaccharides from the wall
fractions of optimal molecular weight for use as
complement fixing antigens.
